1. Home
  2. SRDX vs CCCM Comparison

SRDX vs CCCM Comparison

Compare SRDX & CCCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • CCCM
  • Stock Information
  • Founded
  • SRDX 1979
  • CCCM 2024
  • Country
  • SRDX United States
  • CCCM United States
  • Employees
  • SRDX N/A
  • CCCM N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • CCCM Blank Checks
  • Sector
  • SRDX Health Care
  • CCCM Finance
  • Exchange
  • SRDX Nasdaq
  • CCCM Nasdaq
  • Market Cap
  • SRDX 415.4M
  • CCCM 358.8M
  • IPO Year
  • SRDX 1998
  • CCCM 2025
  • Fundamental
  • Price
  • SRDX $30.91
  • CCCM $10.69
  • Analyst Decision
  • SRDX Buy
  • CCCM
  • Analyst Count
  • SRDX 2
  • CCCM 0
  • Target Price
  • SRDX $43.00
  • CCCM N/A
  • AVG Volume (30 Days)
  • SRDX 92.6K
  • CCCM 187.1K
  • Earning Date
  • SRDX 07-30-2025
  • CCCM 01-01-0001
  • Dividend Yield
  • SRDX N/A
  • CCCM N/A
  • EPS Growth
  • SRDX N/A
  • CCCM N/A
  • EPS
  • SRDX N/A
  • CCCM N/A
  • Revenue
  • SRDX $121,575,000.00
  • CCCM N/A
  • Revenue This Year
  • SRDX N/A
  • CCCM N/A
  • Revenue Next Year
  • SRDX $3.70
  • CCCM N/A
  • P/E Ratio
  • SRDX N/A
  • CCCM N/A
  • Revenue Growth
  • SRDX N/A
  • CCCM N/A
  • 52 Week Low
  • SRDX $26.00
  • CCCM $10.08
  • 52 Week High
  • SRDX $42.25
  • CCCM $17.00
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 65.27
  • CCCM N/A
  • Support Level
  • SRDX $29.51
  • CCCM N/A
  • Resistance Level
  • SRDX $31.06
  • CCCM N/A
  • Average True Range (ATR)
  • SRDX 0.91
  • CCCM 0.00
  • MACD
  • SRDX 0.18
  • CCCM 0.00
  • Stochastic Oscillator
  • SRDX 86.61
  • CCCM 0.00

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About CCCM Columbus Circle Capital Corp I Class A Ordinary Shares

Columbus Circle Capital Corp I is a blank check company.

Share on Social Networks: